Search

Your search keyword '"van der Bij, Wim"' showing total 344 results
Start Over Author "van der Bij, Wim"
344 results on '"van der Bij, Wim"'

9. Long-term outcome and bridging success of patients evaluated and bridged to lung transplantation on the ICU

Author

Gan, C.Tji, primary, Hoek, Rogier A.S., additional, van der Bij, Wim, additional, Van De Wauwer, Caroline, additional, Erasmus, Michiel E., additional, Oude Lansink-Hartgring, Annemiek, additional, Droogh, Joep M., additional, Seghers, Leonard, additional, Mathot, Bas J., additional, Mahtab, Edris A.F., additional, Bekkers, Jos A., additional, Dos Reis Miranda, Dinis, additional, Verschuuren, Erik A.M., additional, and Hellemons, Merel E., additional

Published
2022
Full Text
View/download PDF

11. Predicting 6-minute walking distance in recipients of lung transplantation: longitudinal study of 108 patients

Author

van Adrichem, Edwin J., Reinsma, Gerda D., van den Berg, Sanne, van der Bij, Wim, Erasmus, Michiel E., Krijnen, Wim P., Dijkstra, Pieter U., and van der Schans, Cees P.

Subjects
Lungs -- Transplantation, Exercise -- Usage, Lung diseases -- Diagnosis -- Care and treatment, Muscles -- Health aspects, Health
Abstract

Background. Exercise capacity, muscle function, and physical activity levels remain reduced in recipients of lung transplantation. Factors associated with this deficiency in functional exercise capacity have not been studied longitudinally. Objective. The study aims were to analyze the longitudinal change in 6-minute walking distance and to identify factors contributing to this change. Design. This was a longitudinal historical cohort study. Methods. Data from patients who received a lung transplantation between March 2003 and March 2013 were analyzed for the change in 6-minute walking distance and contributing factors at screening, discharge, and 6 and 12 months after transplantation. Linear mixed-model and logistic regression analyses were performed with data on characteristics of patients, diagnosis, waiting list time, length of hospital stay, rejection, lung function, and peripheral muscle strength. Results. Data from 108 recipients were included. Factors predicting 6-minute walking distance were measurement moment, diagnosis, sex, quadriceps muscle and grip strength, forced expiratory volume in 1 second (percentage of predicted), and length of hospital stay. After transplantation, 6-minute walking distance increased considerably. This initial increase was not continued between 6 and 12 months. At 12 months after lung transplantation, 58.3% of recipients did not reach the cutoff point of 82% of the predicted 6-minute walking distance. Logistic regression demonstrated that discharge values for forced expiratory volume in 1 second and quadriceps or grip strength were predictive for reaching this criterion. Limitations. Study limitations included lack of knowledge on the course of disease during the waiting list period, type and frequency of physical therapy after transplantation, and number of missing data points. Conclusions. Peripheral muscle strength predicted 6-minute walking distance; this finding suggests that quadriceps strength training should be included in physical training to increase functional exercise capacity. Attention should be paid to further increasing 6-minute walking distance between 6 and 12 months after transplantation., Lung transplantation (LTx) as a treatment in end-stage lung disease has become generally accepted for appropriately selected patients. In total, 673 single and double LTxs were performed in the Eurotransplant [...]

Published
2015
Full Text
View/download PDF

15. T cells with an intraepithelial phenotype upregulate cytotoxic function upon influenza infection in human lung

Author

Piet, Berber, de Bree, Godelieve J., Smids-Dierdorp, Barbara S., van der Loos, Chris M., Remmerswaal, Ester B.M., von der Thusen, Jan H., van Haarst, Jan M.W., Eerenberg, Jan P., Brinke, Anja ten, van der Bij, Wim, Timens, Wim, van Lier, Rene A.W., and Jonkers, Rene E.

Subjects
T cells -- Health aspects, Integrins -- Health aspects, Influenza -- Genetic aspects -- Health aspects, Health care industry
Abstract

The human lung T cell compartment contains many [CD8.sup.+] T cells specific for respiratory viruses, suggesting that the lung is protected from recurring respiratory infections by a resident T cell [...]

Published
2011
Full Text
View/download PDF

17. Evaluation of Ten Years Of Parainfluenza virus, human Metapneumovirus And Respiratory Syncytial Virus Infections In Lung Transplant Recipients

Author

de Zwart, Auke E.S., Riezebos‐Brilman, Annelies, Alffenaar, Jan?Willem C., van den Heuvel, Edwin R., Gan, C.T., van der Bij, Wim, Kerstjens, Huib A.M., and Verschuuren, Erik A.M.

Subjects
Coronavirus, COVID-19
Abstract

Respiratory tract infection with Pneumoviruses (PV) and Paramyxoviruses (PMV) are increasingly associated with chronic lung allograft dysfunction (CLAD) in lung transplant recipients (LTR). Ribavirin may be a treatment option but its effectiveness is unclear, especially with respect to infection severity. We retrospectively analyzed ten years of PV/PMV infections in LTR. Main endpoints were FEV1 at three and six months post‐infection, expressed as a percentage of pre‐infection FEV1 and incidence of new or progressed CLAD six months post‐infection. A total of 139 infections were included; 88 (63%) severe infections (defined as >10% FEV1 loss at infection), 51 (37%) mild infections (≤10% FEV1 loss). Overall post‐infection CLAD incidence was 20%. Associations were estimated on post‐infection FEV1 for ribavirin vs. no ribavirin (+13.2% [7.79;18.67]) and severe vs. mild infection (‐11.1% [‐14.76; ‐7.37). Factors associated with CLAD incidence at six months were ribavirin treatment (OR 0.24 [0.10–0.59]), severe infection (OR 4.63 [1.66;12.88]) and mycophenolate mofetil use (OR 0.38 [0.14;0.97]). This data provides valuable information about the outcomes of lung transplant recipients with these infections and suggests possible associations of ribavirin use and infection severity with long‐term outcomes. Well‐designed prospective trials are needed to confirm these findings.

Published
2020

23. Lung Transplantation for Cystic Fibrosis

Author

Adler, Frederick R., Aurora, Paul, Barker, David H., Barr, Mark L., Blackwell, Laura S., Bosma, Otto H., Brown, Samuel, Cox, D. R., Jensen, Judy L., Kurland, Geoffrey, Nossent, George D., Quittner, Alexandra L., Robinson, Walter M., Romero, Sandy L., Spencer, Helen, Sweet, Stuart C., van der Bij, Wim, Vermeulen, J., Verschuuren, Erik A. M., Vrijlandt, Elianne J. L. E., Walsh, William, Woo, Marlyn S., and Liou, Theodore G.

Published
2009
Full Text
View/download PDF

35. Respiratory medicine

Author

Kerstjens, Huib A M, Groen, Harry J, and van der Bij, Wim

Published
2001

36. Respiratory medicine. (Recent advances)

Author

Kerstjens, Huib AM, Groen, Harry J., and van der Bij, Wim

Subjects
Lungs -- Transplantation, Lung diseases, Obstructive -- Forecasts and trends -- Care and treatment, Lung cancer -- Care and treatment, Asthma -- Care and treatment, Health, Market trend/market analysis, Care and treatment, Forecasts and trends
Abstract

Caring for patients with chronic obstructive pulmonary disease (COPD) will present a major challenge over the next decade. Due to a combination of factors including past and present smoking habits [...]

Published
2001

45. Lung transplantation

Author

Broekroelofs, Jan, Navis, Gerjan, Stegeman, Coen A, van der Bij, Wim, and de Jong, Paul E

Published
1998

Catalog

Books, media, physical & digital resources
See catalog results